Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 9/20 | 0.40 |
| ▸ | KIF11 | P52732 | 2/20 | 0.36 |
| ▸ | MAT2A | P31153 | 5/20 | 0.35 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.35 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.35 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22563429 | 0.95 | KIF11 (0.43) | GRM5KIF11MAT2AS1PR1 | |
| SCHEMBL21108014 | 0.91 | GRM5 (0.38) | GRM5KIF11MAT2AS1PR1DGAT1 | |
| SCHEMBL23487712 | 0.89 | KIF11 (0.36) | GRM5KIF11 | |
| SCHEMBL19913276 | 0.88 | GRM5 (0.38) | GRM5KIF11MAT2AS1PR1DGAT1 | |
| SCHEMBL23487688 | 0.88 | RXRA (0.37) | GRM5KIF11DGAT1SOAT1KCNH2 | |
| SCHEMBL22563579 | 0.88 | ALOX5AP (0.35) | GRM5KIF11MAT2ADGAT1SOAT1 | |
| SCHEMBL22268416 | 0.86 | GRM5 (0.39) | GRM5KIF11MAT2AS1PR1DGAT1 | |
| SCHEMBL21108008 | 0.86 | KIF11 (0.43) | GRM5KIF11MAT2AS1PR1PDE10A | |
| SCHEMBL22563506 | 0.85 | USP14 (0.38) | GRM5 | |
| SCHEMBL23487711 | 0.84 | PTGER4 (0.34) | GRM5KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210175434-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-06-10 | — | — | US | disclosed |
| EP-3580300-B1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2020-10-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210175434-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, OR51E2, OCIAD2 | GRM5 3519/4885KIF11 3067/4885MAT2A 1269/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.